Jared Peters Smit

USPTO Granted Patents = 9 (Patent Applications = 5)

EPO Patents = 2 (Patent Applications = 1)

Average Co-Inventor Count = 6.2

ph-index = 4

Forward Citations = 30(Granted Patents)

Company Filing History:

4 out of 63

Salix Pharmaceuticals, Inc.

patents

2 out of 61

Reata Pharmaceuticals, Inc.

Eli Lilly and Company

patents

Years Active: 2012-2022

where 'Filed Patents' based on already Granted Patents

9 patents (USPTO):Sort by Forward Citations

Abstract keywords

1. 11401294 - Co-crystal forms of a novobiocin analog and proline (2022-08-02),

2. 10717755 - Co-crystal forms of a novobiocin analog and proline (2020-07-21),

3. 10428072 - Inhibiting the transient receptor potential A1 ion channel (2019-10-01),

4. 9982007 - Cocrystals of progesterone (2018-05-29),

5. 9512166 - Cocrystals of progesterone (2016-12-06),

6. 9133217 - Forms of rifaximin and uses thereof (2015-09-15),

7. 8735419 - Forms of rifaximin and uses thereof (2014-05-27),

8. 8507517 - Forms of rifaximin and uses thereof (2013-08-13),

9. 8227482 - Forms of rifaximin and uses thereof (2012-07-24),

Title: The Innovative Journey of Jared Peters Smit

Introduction

Jared Peters Smit is a notable inventor based in Lafayette, IN (US). He has made significant contributions to the field of pharmaceuticals, particularly in developing novel treatments for neurodegenerative disorders. With a total of nine patents to his name, Smit's work continues to impact the medical community.

Latest Patents

Among his latest patents are the co-crystal forms of a novobiocin analog and proline. These patents disclose co-crystal forms of N-(2-(5-(((2R,3R,4S,5R)-3,4-dihydroxy-5-methoxy-6,6-dimethyltetra-hydro-2H-pyran-2-yl)oxy)-3'-fluoro-[1,1′-biphenyl]-2-yl)ethyl)-acetamide and L-proline or D-proline. The pharmaceutical compositions, processes of manufacture, and methods of use for these compounds are aimed at treating neurodegenerative disorders such as diabetic peripheral neuropathy.

Career Highlights

Smit has worked with prominent companies in the pharmaceutical industry, including Salix Pharmaceuticals, Inc. and Reata Pharmaceuticals, Inc. His experience in these organizations has allowed him to refine his skills and contribute to groundbreaking research and development.

Collaborations

Some of his notable coworkers include Patricia Andres and Stephan D Parent. Their collaborative efforts have further advanced the research and development of innovative pharmaceutical solutions.

Conclusion

Jared Peters Smit's contributions to the field of pharmaceuticals through his patents and collaborations highlight his dedication to improving treatments for neurodegenerative disorders. His innovative work continues to inspire advancements in medical research and development.

This text is generated by artificial intelligence and may not be accurate.